Skip to Content

R 539 (Carbidopa and levodopa 25 mg / 100 mg)

Pill imprint R 539 has been identified as Carbidopa and levodopa 25 mg / 100 mg.

Carbidopa/levodopa is used in the treatment of restless legs syndrome; parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 100 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Carbidopa and levodopa 25 mg / 100 mg R 539
Carbidopa and levodopa 25 mg / 100 mg R 539
Carbidopa and levodopa 25 mg / 100 mg R 539 Front
Carbidopa and levodopa 25 mg / 100 mg R 539 Back
Carbidopa and levodopa
25 mg / 100 mg
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
National Drug Code (NDC):
Inactive Ingredients:
corn starch
D&C Yellow No. 10
FD&C Yellow No. 6
magnesium stearate
microcrystalline cellulose
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68084-0093 Amerisource Health Services
00904-6237 Major Pharmaceuticals
54868-1334 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.